百利天恒<span style='color:#FB4747'>全球</span><span style='color:#FB4747'>首创</span>双抗 ADC 临床试验<span style='color:#FB4747'>获</span>新进展，港股创<span style='color:#FB4747'>新药</span>ETF 博时 ( 520690 ) 盘中最高涨超 1%，冲击 3 连涨
“ 受理到<span style='color:#FB4747'>获</span>批仅 6 个月 ”！五款<span style='color:#FB4747'>新药</span>同日放行 实体瘤 CAR-T、双抗 ADC 迎<span style='color:#FB4747'>全球</span><span style='color:#FB4747'>首创</span>
打破心血管诊断 “ 隐形的墙 ”——<span style='color:#FB4747'>全球</span><span style='color:#FB4747'>首创</span>1 类创<span style='color:#FB4747'>新药</span>“ 盐酸去甲乌药碱注射液 ”<span style='color:#FB4747'>获</span>批上市
没有更多数据了
